Valuation Charles River Laboratories International, Inc. Berne S.E.

Stocks

End-of-day quote Berne S.E. 28/09/2026			5-day change	1st Jan Change
243.60 ^CHF	+0.92%		+6.87%	-

09-28	Jefferies Adjusts PT on Charles River Laboratories International to $340 From $305, Maintains Buy Rating	MT
09-25	Charles River Laboratories's DAS Segment Faces Largest Margin Upside, RBC Says	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	18,941	11,138	12,252	9,520	10,023	14,063	-	-
Change	-	-41.2%	10%	-22.3%	5.29%	40.31%	-	-
Enterprise Value (EV) ¹	21,366	13,616	14,622	11,565	11,946	16,176	15,697	15,303
Change	-	-36.28%	7.39%	-20.91%	3.29%	35.41%	-2.96%	-2.51%
P/E	49.4x	23.1x	25.9x	931x	-70x	78.3x	31.5x	28.1x
PBR	7.45x	3.75x	3.41x	2.75x	3.17x	4.67x	3.97x	3.53x
PEG	-	0.9x	-9.44x	-9.5x	0x	-0x	0x	2.3x
Capitalization / Revenue	5.35x	2.8x	2.97x	2.35x	2.5x	3.59x	3.51x	3.32x
EV / Revenue	6.04x	3.42x	3.54x	2.86x	2.98x	4.13x	3.92x	3.62x
EV / EBITDA	24.3x	13.7x	14.4x	11.6x	12.3x	15.8x	14.1x	12.8x
EV / EBIT	28.8x	16.3x	17.4x	14.3x	15x	19.7x	17.1x	15.1x
EV / FCF	40.2x	46.2x	40x	23.1x	23x	50.9x	25.6x	32.2x
FCF Yield	2.49%	2.17%	2.5%	4.34%	4.34%	1.97%	3.91%	3.11%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	7.6	9.48	9.22	0.2	-2.91	3.763	9.362	10.5
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	3,540	3,976	4,129	4,050	4,015	3,919	4,006	4,232
EBITDA ¹	879.5	990.9	1,013	996.1	971.5	1,024	1,112	1,192
EBIT ¹	742.1	834	838.8	805.9	793.9	821.9	916.6	1,014
Net income ¹	391	486.2	474.6	10.3	-144.3	164.1	431.1	475.7
Net Debt ¹	2,425	2,477	2,370	2,046	1,923	2,112	1,633	1,239
Reference price ²	375.34	218.92	238.84	186.16	203.66	294.59	294.59	294.59
Nbr of stocks (in thousands)	50,464	50,879	51,297	51,136	49,215	47,739	-	-
Announcement Date	16/02/22	22/02/23	14/02/24	19/02/25	18/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
LONZA GROUP AG	34.14x	6.12x	18.32x	0.95%	49.06B
IQVIA HOLDINGS INC.	34.9x	3.36x	14.48x	-.--%	44.6B
REVOLUTION MEDICINES, INC.	-20.74x	225.54x	-22.4x	-.--%	43.24B
BEONE MEDICINES AG	48.07x	5.56x	30.53x	-.--%	41.73B
CELLTRION, INC.	26.98x	7.78x	20.03x	0.42%	29.93B
MEDPACE HOLDINGS, INC.	35.03x	5.75x	26.11x	-.--%	17.19B
TEMPUS AI, INC.	-61.09x	9.99x	243.97x	-.--%	15.35B
EUROFINS SCIENTIFIC SE	26.24x	2.25x	9.73x	1.02%	15.54B
Average	15.44x	33.29x	42.60x	0.3%	32.08B
Weighted average by Cap.	20.34x	42.68x	26.48x	0.29%